Core Viewpoint - The "Three-Year Action Plan for Accelerating the High-Quality Development of Traditional Chinese Medicine Industry in Hainan Province (2026-2028)" is the first traditional Chinese medicine work plan approved by the provincial government since the operation of the Hainan Free Trade Port, serving as a guideline for the development of the traditional Chinese medicine industry in the province over the next three years [1] Group 1: Action Plan Features - The action plan emphasizes "three combinations," "four efforts," and "four breakthroughs" [2] - The "four efforts" focus on consolidating primary industry, strengthening secondary industry, expanding tertiary industry, and promoting open development, detailing 16 key tasks [2] - The plan aims to enhance the core functions of traditional Chinese medicine manufacturing, promote innovative transformation of medical institution preparations, and support technological upgrades and research in traditional medicine enterprises [2] Group 2: Industry Development and Resources - Hainan Province has over 2,000 types of traditional Chinese medicine resources, with unique southern medicines accounting for over 90% of national production [4] - The province has established four national and provincial resource nurseries, preserving over 2,800 live resources and cultivating 63 new varieties [4] - By 2025, the plan allocates 10 million yuan to support the establishment of provincial-level advantageous characteristic southern medicine industry clusters in central counties [5] Group 3: Tourism and Experience Integration - The action plan envisions expanding the tertiary industry by integrating traditional Chinese medicine with cultural tourism, creating a health tourism destination [6] - It proposes immersive health restoration products such as "rainforest healing" and "hot spring medicinal baths," leveraging Hainan's unique ecological resources [6] - The plan aims to innovate experience products and promote the synergy of local cuisine and traditional Chinese medicine [6]

Core Viewpoint - The acceleration of traditional Chinese medicine (TCM) centralized procurement aims to address the long-standing issue of inflated prices in the TCM market, with significant price reductions observed in recent procurement rounds [1][6][9] Group 1: Price Reduction and Procurement Process - The average price reduction for selected TCM products in the third batch of centralized procurement reached 68%, with some products seeing reductions over 90% [1] - The first batch of TCM centralized procurement in 2021 resulted in an average price reduction of 42.27%, while the second batch in 2023 saw a reduction of 49.36% [3] - The third batch of procurement included 19 unique products, with an average price reduction of 47.38% [3] Group 2: Governance and Long-term Mechanisms - Experts suggest that a long-term mechanism for price governance should involve both centralized procurement and regular monitoring of listed prices to identify anomalies [1][2] - The establishment of a robust procurement credit system is essential to ensure that high-priced products are closely monitored for sales performance [2] Group 3: Challenges in the TCM Market - The high prices of TCM are attributed to various factors, including the impact of climate on raw material prices, insufficient market competition, and the complexity of pricing structures [6][7] - The presence of monopolistic practices in the TCM sector leads to concentrated pricing power, exacerbating the issue of inflated prices [7] Group 4: Regional Implementation and Impact - Various provinces, including Guangdong and Jiangsu, are actively implementing centralized procurement to ensure that selected products are available in hospitals and to manage prices effectively [4] - The expected annual savings for patients from the recent procurement efforts are estimated to exceed 31 million yuan [4] Group 5: Future Recommendations - Recommendations for future procurement processes include establishing a reasonable price increase mechanism during supply shortages and ensuring transparency in production costs [5] - A national collaborative governance framework is proposed to standardize pricing rules and monitor price fluctuations across provinces [9][10]